Common TitleSWAP
Official Title Efficacy and Safety of Switching From AZT to Tenofovir
Phase Phase IV
ClinicalTrials.gov NCT00647244
Categories PharmacologyTreatment-ExperiencedSwitch/SimplificationAdverse Effects
Funding
IndustryGlaxoSmithKline
References
- Rasmussen TA, Jensen D, Tolstrup M, et al. Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial. PLoS One. 2012;7:e32445.